Thrombosis in ischemic heart disease

J A Ambrose1, M Weinrauch

  • 1Department of Medicine, Mount Sinai Medical Center, New York, NY, USA.

Insights

Thrombus formation in atherosclerosis drives acute coronary syndromes and disease progression. Current treatments dissolve or prevent thrombus extension, while new strategies focus on plaque stabilization and reduced hypercoagulability.

Area of Science:

  • Cardiovascular Medicine
  • Pathophysiology
  • Interventional Cardiology

Background:

  • Atherosclerotic plaque disruption initiates thrombus formation, a key mechanism in acute coronary syndromes like myocardial infarction and unstable angina.
  • Thrombus formation contributes to chronic atherosclerotic disease progression and restenosis after coronary angioplasty.
  • Current therapeutic strategies for thrombus involve pharmacological agents and intracoronary interventions.

Purpose of the Study:

  • To review the pathogenetic mechanisms of thrombus formation in atherosclerosis.
  • To outline current therapeutic approaches for managing intracoronary thrombus.
  • To discuss emerging strategies for the primary prevention of thrombus formation.

Main Methods:

  • Literature review of pathogenetic mechanisms of thrombus formation.
  • Analysis of current pharmacological and interventional treatments for thrombus.
  • Examination of ongoing and recent clinical trials for plaque stabilization and hypercoagulability reduction.

Main Results:

  • Thrombus formation is central to myocardial infarction (arterial occlusion) and unstable angina (mural thrombus).
  • Therapeutic interventions aim to prevent thrombus extension, dissolve fibrin, inhibit platelet aggregation, or mechanically open arteries.
  • Primary prevention strategies, including plaque stabilization and reducing hypercoagulability, are under investigation.

Conclusions:

  • Thrombus formation is a critical determinant in acute coronary syndromes and atherosclerotic disease progression.
  • Effective management requires a combination of antithrombotic therapies and revascularization techniques.
  • Future research focuses on primary prevention through plaque modification and modulation of coagulation pathways.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...